Greg Moeck

11PUBLICATIONS
25CO-AUTHORS
Microbial ecologyMedical bacteriologyMolecular targetsBacteriologyMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 23, 2025
Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying blaOXA-48.

Maria F Mojica, Elise T Zeiser, Scott A Becka

|Aug 19, 2025
Establishing the reference broth microdilution MIC method for cefepime-taniborbactam.

Adam Belley, Susan M Cusick, Dan C Pevear

|Jul 31, 2025
Assessment of human exposures of cefepime-taniborbactam against cefepime-resistant Enterobacterales and Pseudomonas aeruginosa in a 7-day hollow fiber infection model.

Lindsay M Avery, Mitchell Edwards, Fan Yi

|Apr 01, 2025
Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic Escherichia coli strains.

Tsuyoshi Uehara, Cassandra L Chatwin, Brittany Miller

|Oct 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten.

Michael R Jacobs, Caryn E Good, Ayman M Abdelhamed

|Sep 24, 2024
Cefepime-taniborbactam demonstrates potent in vitro activity vs Enterobacterales with blaOXA-48.

Maria F Mojica, Elise T Zeiser, Scott A Becka

Pageof 2

Frequent Collaborators

5 joint publications

Tsuyoshi Uehara

5 joint publications

David A Six

4 joint publications

Krisztina M Papp-Wallace

3 joint publications

Robert A Bonomo